These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4846326)

  • 21. Dopa-induced locomotor stimulation after inhibition of extracerebral decarboxylase.
    Bartholini G; Blum JE; Pletscher A
    J Pharm Pharmacol; 1969 May; 21(5):297-301. PubMed ID: 4390121
    [No Abstract]   [Full Text] [Related]  

  • 22. ET495 and brain catecholamine mechanisms: evidence for stimulation of dopamine receptors.
    Corrodi H; Farnebo LO; Fuxe K; Hamberger B; Ungerstedt U
    Eur J Pharmacol; 1972 Nov; 20(2):195-204. PubMed ID: 4651208
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of a decarboxylase inhibitor on the Dopa and 5-HTP induced changes in the locomotor-like discharge pattern of rabbit hind limb nerves.
    Viala D; Buser P
    Psychopharmacologia; 1974; 40(3):225-33. PubMed ID: 4548539
    [No Abstract]   [Full Text] [Related]  

  • 24. Noradrenaline synthesis and utilization: control by nerve impulse flow under normal conditions and after treatment with alpha-adrenoreceptor blocking agents.
    Grabowska M; Andén NE
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(1):53-8. PubMed ID: 6919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hypertension: 3 H-catecholamine metabolism in the adrenal glands and brain and tissue metabolism of 3 3 H-DOPA during reserpine, alpha-methyl DOPA and ST-155 administration in spontaneously hypertensive rats].
    Hashida J
    Nihon Naibunpi Gakkai Zasshi; 1973 Jan; 49(1):80-97. PubMed ID: 4734773
    [No Abstract]   [Full Text] [Related]  

  • 26. Biochemical pharmacology of catecholamines and its clinical implications.
    Axelrod J
    Trans Am Neurol Assoc; 1971; 96():179-86. PubMed ID: 4400652
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of L-DOPA and analogues on central dopamine and noradrenaline mechanisms.
    Andén NE; Engel J
    Adv Neurol; 1974; 5():317-24. PubMed ID: 4613158
    [No Abstract]   [Full Text] [Related]  

  • 28. The induction and antagonism of central nervous system stimulant-induced stereotyped behavior in the cat.
    Wallach MB; Gershon S
    Eur J Pharmacol; 1972 Apr; 18(1):22-6. PubMed ID: 5031271
    [No Abstract]   [Full Text] [Related]  

  • 29. Reversal by L-DOPA of the suppression of locomotor activity induced by inhibition of tyrosine-hydroxylase and DA-beta-hydroxylase in mice.
    Ahlenius S
    Brain Res; 1974 Mar; 69(1):57-65. PubMed ID: 4150408
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacological studies on a possible role of central noradrenaline neurons in respiratory control.
    Bolme P; Fuxe K
    J Pharm Pharmacol; 1973 Apr; 25(4):351-2. PubMed ID: 4146697
    [No Abstract]   [Full Text] [Related]  

  • 31. An analysis of DOPA-induced locomotor stimulation in mice with inhibited extracerebral decarboxylase.
    Przegaliński E; Kleinrok Z
    Psychopharmacologia; 1972; 23(3):279-88. PubMed ID: 4260342
    [No Abstract]   [Full Text] [Related]  

  • 32. The interaction between different metabolic pathways of catecholamines in the brain studied by means of 3H-DOPA.
    Persson T; Waldeck B
    Acta Pharmacol Toxicol (Copenh); 1969; 27(2):225-36. PubMed ID: 5819576
    [No Abstract]   [Full Text] [Related]  

  • 33. Suppression of noradrenaline synthesis in sympathetic nerves by carbidopa, an inhibitor of peripheral dopa decarboxylase.
    Wurtman RJ; Watkins CJ
    Nature; 1977 Jan; 265(5589):79-80. PubMed ID: 834247
    [No Abstract]   [Full Text] [Related]  

  • 34. Behavioral, biochemical, and histochemical analyses of the central effects of monoamine precursors after peripheral decarboxylase inhibition.
    Butcher LL; Engel J; Fuxe K
    Brain Res; 1972 Jun; 41(2):387-411. PubMed ID: 4402607
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of ethanol on the hydroxylation of tyrosine and tryptophan in rat brain in vivo.
    Carlsson A; Lindqvist M
    J Pharm Pharmacol; 1973 Jun; 25(6):437-40. PubMed ID: 4146580
    [No Abstract]   [Full Text] [Related]  

  • 36. Brain capillaries as a source of homovanillic acid in cerebrospinal fluid.
    Bartholini G; Tissot R; Pletscher A
    Brain Res; 1971 Mar; 27(1):163-8. PubMed ID: 5554221
    [No Abstract]   [Full Text] [Related]  

  • 37. The importance of monoamine metabolism for the pathology of the extrapyramidal system.
    Birkmayer W
    J Neurovisc Relat; 1969; 31():Suppl 9:297+. PubMed ID: 4319516
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of chronic ethanol administration on central neurotransmitter mechanisms.
    Liljequist S; Engel J
    Med Biol; 1979 Aug; 57(4):199-210. PubMed ID: 41985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L-3,4-dihydroxyphenylalanine-induced of norepinephrine from the rat heart.
    Landsberg L
    Biochem Pharmacol; 1971 Dec; 20(12):3542-7. PubMed ID: 5132898
    [No Abstract]   [Full Text] [Related]  

  • 40. Ethanol enhances, but diazepam and pentobarbital reduce the ambulation-increasing effect of caffeine in mice.
    Kuribara H; Asahi T; Tadokoro S
    Arukoru Kenkyuto Yakubutsu Ison; 1992 Oct; 27(5):528-39. PubMed ID: 1449412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.